These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 25404446)

  • 1. Prognostic role of SIRT1 in hepatocellular carcinoma.
    Song S; Luo M; Song Y; Liu T; Zhang H; Xie Z
    J Coll Physicians Surg Pak; 2014 Nov; 24(11):849-54. PubMed ID: 25404446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SIRT1 regulates YAP2-mediated cell proliferation and chemoresistance in hepatocellular carcinoma.
    Mao B; Hu F; Cheng J; Wang P; Xu M; Yuan F; Meng S; Wang Y; Yuan Z; Bi W
    Oncogene; 2014 Mar; 33(11):1468-74. PubMed ID: 23542177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SIRT1 regulates oncogenesis via a mutant p53-dependent pathway in hepatocellular carcinoma.
    Zhang ZY; Hong D; Nam SH; Kim JM; Paik YH; Joh JW; Kwon CH; Park JB; Choi GS; Jang KY; Park CK; Kim SJ
    J Hepatol; 2015 Jan; 62(1):121-30. PubMed ID: 25131770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and role of SIRT1 in hepatocellular carcinoma.
    Choi HN; Bae JS; Jamiyandorj U; Noh SJ; Park HS; Jang KY; Chung MJ; Kang MJ; Lee DG; Moon WS
    Oncol Rep; 2011 Aug; 26(2):503-10. PubMed ID: 21567102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetylation status of P53 and the expression of DBC1, SIRT1, and androgen receptor are associated with survival in clear cell renal cell carcinoma patients.
    Noh SJ; Kang MJ; Kim KM; Bae JS; Park HS; Moon WS; Chung MJ; Lee H; Lee DG; Jang KY
    Pathology; 2013 Oct; 45(6):574-80. PubMed ID: 24018803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of SIRT1 promotes metastasis through epithelial-mesenchymal transition in hepatocellular carcinoma.
    Hao C; Zhu PX; Yang X; Han ZP; Jiang JH; Zong C; Zhang XG; Liu WT; Zhao QD; Fan TT; Zhang L; Wei LX
    BMC Cancer; 2014 Dec; 14():978. PubMed ID: 25522783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sirtuin 1 is upregulated in a subset of hepatocellular carcinomas where it is essential for telomere maintenance and tumor cell growth.
    Chen J; Zhang B; Wong N; Lo AW; To KF; Chan AW; Ng MH; Ho CY; Cheng SH; Lai PB; Yu J; Ng HK; Ling MT; Huang AL; Cai XF; Ko BC
    Cancer Res; 2011 Jun; 71(12):4138-49. PubMed ID: 21527554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SIRT1 and c-Myc promote liver tumor cell survival and predict poor survival of human hepatocellular carcinomas.
    Jang KY; Noh SJ; Lehwald N; Tao GZ; Bellovin DI; Park HS; Moon WS; Felsher DW; Sylvester KG
    PLoS One; 2012; 7(9):e45119. PubMed ID: 23024800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WWC2 is an independent prognostic factor and prevents invasion via Hippo signalling in hepatocellular carcinoma.
    Zhang Y; Yan S; Chen J; Gan C; Chen D; Li Y; Wen J; Kremerskothen J; Chen S; Zhang J; Cao Y
    J Cell Mol Med; 2017 Dec; 21(12):3718-3729. PubMed ID: 28815883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. YAP and TAZ Heterogeneity in Primary Liver Cancer: An Analysis of Its Prognostic and Diagnostic Role.
    Van Haele M; Moya IM; Karaman R; Rens G; Snoeck J; Govaere O; Nevens F; Verslype C; Topal B; Monbaliu D; Halder G; Roskams T
    Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30717258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrator complex subunit 6 (INTS6) inhibits hepatocellular carcinoma growth by Wnt pathway and serve as a prognostic marker.
    Lui KY; Zhao H; Qiu C; Li C; Zhang Z; Peng H; Fu R; Chen HA; Lu MQ
    BMC Cancer; 2017 Sep; 17(1):644. PubMed ID: 28899352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of Rac GTPase Activating Protein 1 Contributes to Proliferation of Cancer Cells by Reducing Hippo Signaling to Promote Cytokinesis.
    Yang XM; Cao XY; He P; Li J; Feng MX; Zhang YL; Zhang XL; Wang YH; Yang Q; Zhu L; Nie HZ; Jiang SH; Tian GA; Zhang XX; Liu Q; Ji J; Zhu X; Xia Q; Zhang ZG
    Gastroenterology; 2018 Oct; 155(4):1233-1249.e22. PubMed ID: 30009820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SIRT1 promotes tumorigenesis and resistance to chemotherapy in hepatocellular carcinoma and its expression predicts poor prognosis.
    Chen HC; Jeng YM; Yuan RH; Hsu HC; Chen YL
    Ann Surg Oncol; 2012 Jun; 19(6):2011-9. PubMed ID: 22146883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma.
    Li C; Wu M; Zong G; Wan C; Liu Q; Zhou H; Hua L; Chen Y; Chen X; Lu C
    Dig Dis Sci; 2017 Jan; 62(1):133-142. PubMed ID: 27921263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression Pattern and Clinical Significance of Gab2 Protein in Hepatocellular Carcinoma.
    Hu X; He B; Zhou L; Xie H; Zheng S
    Clin Lab; 2016; 62(6):1087-92. PubMed ID: 27544933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The tumor suppressor role of Src homology phosphotyrosine phosphatase 2 in hepatocellular carcinoma.
    Jiang C; Hu F; Tai Y; Du J; Mao B; Yuan Z; Wang Y; Wei L
    J Cancer Res Clin Oncol; 2012 Apr; 138(4):637-46. PubMed ID: 22228034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SIRT7 regulates hepatocellular carcinoma response to therapy by altering the p53-dependent cell death pathway.
    Zhao J; Wozniak A; Adams A; Cox J; Vittal A; Voss J; Bridges B; Weinman SA; Li Z
    J Exp Clin Cancer Res; 2019 Jun; 38(1):252. PubMed ID: 31196136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation of Hippo Pathway Is Significantly Associated with Poor Prognosis in Hepatocellular Carcinoma.
    Sohn BH; Shim JJ; Kim SB; Jang KY; Kim SM; Kim JH; Hwang JE; Jang HJ; Lee HS; Kim SC; Jeong W; Kim SS; Park ES; Heo J; Kim YJ; Kim DG; Leem SH; Kaseb A; Hassan MM; Cha M; Chu IS; Johnson RL; Park YY; Lee JS
    Clin Cancer Res; 2016 Mar; 22(5):1256-64. PubMed ID: 26459179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential SIRT1 expression in hepatocellular carcinomas and cholangiocarcinoma of the liver.
    Al-Bahrani R; Tuertcher D; Zailaie S; Abuetabh Y; Nagamori S; Zetouni N; Bahitham W; Sergi C
    Ann Clin Lab Sci; 2015; 45(1):3-9. PubMed ID: 25696003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic and predicted significance of Ubqln2 in patients with hepatocellular carcinoma.
    Luo YD; Yu HQ; Liu XY; Huang D; Dai HS; Fang L; Zhang YJ; Lai JJ; Jiang Y; Shuai L; Zhang LD; Chen G; Bie P; Xie CM
    Cancer Med; 2020 Jun; 9(12):4083-4094. PubMed ID: 32293796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.